BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29779029)

  • 21. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of plasma indoxyl sulfate levels and estimated glomerular filtration rate to left ventricular diastolic dysfunction.
    Sato B; Yoshikawa D; Ishii H; Suzuki S; Inoue Y; Takeshita K; Tanaka M; Kumagai S; Matsumoto M; Okumura S; Hayashi M; Matsubara T; Niwa T; Murohara T
    Am J Cardiol; 2013 Mar; 111(5):712-6. PubMed ID: 23228923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection of subclinical left ventricular myocardial dysfunction in patients with chronic kidney disease.
    Panoulas VF; Sulemane S; Konstantinou K; Bratsas A; Elliott SJ; Dawson D; Frankel AH; Nihoyannopoulos P
    Eur Heart J Cardiovasc Imaging; 2015 May; 16(5):539-48. PubMed ID: 25428945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients.
    Choi ST; Kim JS; Song JS
    J Korean Med Sci; 2014 Jun; 29(6):788-92. PubMed ID: 24932079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Change in plasma H2S level and therapeutic effect of H2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction].
    Zhao DA; Liu J; Huang Q; Han ZM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Oct; 15(10):903-8. PubMed ID: 24131846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous H
    Breza J; Soltysova A; Hudecova S; Penesova A; Szadvari I; Babula P; Chovancova B; Lencesova L; Pos O; Breza J; Ondrias K; Krizanova O
    BMC Cancer; 2018 May; 18(1):591. PubMed ID: 29793450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurements of echocardiographic indices and biomarkers of kidney injury in dogs with chronic kidney disease.
    Hezzell MJ; Foster JD; Oyama MA; Buch J; Farace G; Quinn JJ; Yerramilli M
    Vet J; 2020 Jan; 255():105420. PubMed ID: 31982083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease.
    Aminzadeh MA; Vaziri ND
    Nephrol Dial Transplant; 2012 Feb; 27(2):498-504. PubMed ID: 22036943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between plasma soluble RAGE and renal function is unaffected by medication usage and enzymatic antioxidants in chronic kidney disease with type 2 diabetes.
    Wong FN; Tan JA; Keng TC; Ng KP; Chua KH; Kuppusamy UR
    Clin Chim Acta; 2016 Jan; 453():56-61. PubMed ID: 26657980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.
    Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Satanovskij R; Angermann S; Hasenau AL; Stecher L; Heemann U; Renders L; Scherberich J
    Medicine (Baltimore); 2016 Mar; 95(10):e3011. PubMed ID: 26962815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.
    Kikuchi H; Kanda E; Mandai S; Akazawa M; Iimori S; Oi K; Naito S; Noda Y; Toda T; Tamura T; Sasaki S; Sohara E; Okado T; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):55-62. PubMed ID: 26920126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.
    Yilmaz G; Ustundag S; Temizoz O; Sut N; Demir M; Ermis V; Sevinc C; Ustundag A
    Clin Lab; 2015; 61(8):1061-70. PubMed ID: 26427152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
    Bansal N; Zelnick L; Shlipak MG; Anderson A; Christenson R; Deo R; deFilippi C; Feldman H; Lash J; He J; Kusek J; Ky B; Seliger S; Soliman EZ; Go AS;
    Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrogen Sulfide Protects Hyperhomocysteinemia-Induced Renal Damage by Modulation of Caveolin and eNOS Interaction.
    Pushpakumar S; Kundu S; Sen U
    Sci Rep; 2019 Feb; 9(1):2223. PubMed ID: 30778103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
    Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS
    J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
    Levi A; Cohen E; Levi M; Goldberg E; Garty M; Krause I
    Eur J Intern Med; 2014 Dec; 25(10):951-5. PubMed ID: 25457436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort.
    Wolke C; Teumer A; Endlich K; Endlich N; Rettig R; Stracke S; Fiene B; Aymanns S; Felix SB; Hannemann A; Lendeckel U
    Exp Biol Med (Maywood); 2017 Mar; 242(5):554-563. PubMed ID: 28038565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of hemoglobin concentration on plasma B-type natriuretic peptide level and left ventricle echocardiographics characteristics in chronic kidney disease patients.
    Rasić S; Hadzović-Dzuvo A; Tomić M; Uncanin S; Corić S
    Coll Antropol; 2009 Dec; 33 Suppl 2():141-4. PubMed ID: 20120531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction.
    Hayashi M; Yasuda Y; Suzuki S; Tagaya M; Ito T; Kamada T; Yoshinaga M; Sugishita Y; Fujiwara W; Yokoi H; Ozaki Y; Izawa H
    Heart Vessels; 2017 Mar; 32(3):279-286. PubMed ID: 27385024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.